A new method for reduction of endotoxin contamination from protein solutions - PubMed (original) (raw)
A new method for reduction of endotoxin contamination from protein solutions
T E Karplus et al. J Immunol Methods. 1987.
Abstract
A method of reducing endotoxin contamination in protein-containing solutions is described here using a combination of polymyxin B-Sepharose 4B (PB-Seph 4B) affinity binding and endotoxin-protein dissociation with the dialyzable surfactant, octyl-beta-D-glucopyranoside (OBDG). Using the limulus amoebocyte lysate (LAL) assay to detect endotoxin, greater than 1000-fold reduction of endotoxin reactivity could be accomplished from a contaminated commercial preparation of bovine catalase. Importantly, this occurred with only a 24% protein loss and an 11% loss of catalase enzymatic activity after treatment. The treated catalase appeared to be largely endotoxin-free since it no longer elicited a pyrogenic response in rabbits or primed for intravascular coagulation of the generalized Shwartzman reaction. Of interest, OBDG treatment of Salmonella minnesota Re595 lipopolysaccharide enhanced its ability to bind to serum high density lipoproteins which might contribute to decreased in vivo toxicity. In quantitative studies using radiolabeled endotoxin, the OBDG was shown to be capable of dissociating protein-bound endotoxin thereby facilitating its binding to the PB-Seph 4B adduct. The technique was also useful in removing radiolabeled endotoxin added to human IgG. The methodology described here would be expected to have general usefulness in reducing endotoxin contamination of macromolecular solutions that can bind and retain endotoxin.
Similar articles
- Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
Pool EJ, Johaar G, James S, Petersen I, Bouic P. Pool EJ, et al. J Immunoassay. 1999 Feb-May;20(1-2):79-89. doi: 10.1080/01971529909349315. J Immunoassay. 1999. PMID: 10225516 - Detection of pyrogens in intravenous IgG preparations.
Huszár G, Jenei B, Szabó G, Medgyesi GA. Huszár G, et al. Biologicals. 2002 Jun;30(2):77-83. doi: 10.1006/biol.2001.0311. Biologicals. 2002. PMID: 12127308 - Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli.
Dinarello CA, O'Connor JV, LoPreste G, Swift RL. Dinarello CA, et al. J Clin Microbiol. 1984 Sep;20(3):323-9. doi: 10.1128/jcm.20.3.323-329.1984. J Clin Microbiol. 1984. PMID: 6386853 Free PMC article. - [LAL (Limulus Amoebocyte Lysate) test as applied to the safety evaluation of biological preparations].
Aleksandrowicz J, Kudelski Z. Aleksandrowicz J, et al. Rocz Panstw Zakl Hig. 1997;48(3):275-82. Rocz Panstw Zakl Hig. 1997. PMID: 9432705 Review. Polish. - Endotoxin removal from protein solutions.
Petsch D, Anspach FB. Petsch D, et al. J Biotechnol. 2000 Jan 21;76(2-3):97-119. doi: 10.1016/s0168-1656(99)00185-6. J Biotechnol. 2000. PMID: 10656326 Review.
Cited by
- Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leucocyte transmigration through human endothelial cells in vitro.
Galdiero M, Folgore A, Molitierno M, Greco R. Galdiero M, et al. Clin Exp Immunol. 1999 Jun;116(3):453-61. doi: 10.1046/j.1365-2249.1999.00904.x. Clin Exp Immunol. 1999. PMID: 10361234 Free PMC article. - Preparative purification of recombinant proteins: current status and future trends.
Saraswat M, Musante L, Ravidá A, Shortt B, Byrne B, Holthofer H. Saraswat M, et al. Biomed Res Int. 2013;2013:312709. doi: 10.1155/2013/312709. Epub 2013 Dec 17. Biomed Res Int. 2013. PMID: 24455685 Free PMC article. Review. - Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo.
von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. von Andrian UH, et al. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7538-42. doi: 10.1073/pnas.88.17.7538. Proc Natl Acad Sci U S A. 1991. PMID: 1715568 Free PMC article. - Early detection of allergic diseases in otorhinolaryngology.
Klimek L, Schendzielorz P. Klimek L, et al. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008;7:Doc04. doi: 10.3205/cto000049. Epub 2010 Oct 7. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2008. PMID: 22073091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources